ATS View
한국어

InBody KRX:041830KOSDAQ

인바디 · Korean news coverage and regulatory filings, organized.

한국어
Articles, 24h8
Articles, 7 days10
DART filings, 7 days0
Articles tracked38since Sep 11

In Q2 2026, InBody reported revenue of ₩73.3bn, up 30.4% year on year, and operating profit of ₩17.7bn. InBody (인바디) appeared in 10 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 30 with 8 articles. It was most often mentioned alongside 글로벌테크놀로지, L&C Bio and Classys.

Filing signals Profit +50% Revenue +30% Revenue & profit growth Op. margin 20%+ Dividend grower Major holder adding Share pledge Screener

InBody quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩73.3bn+30.4%₩17.7bn
margin 24.2%		₩14.5bn
Q1 2026₩68.4bn+23.1%₩13.0bn
margin 19.0%		₩16.3bn
Q4 2025 derived₩62.4bn+13.3%₩9.5bn
margin 15.3%		₩6.4bn
Q3 2025₩59.8bn+17.9%₩9.8bn
margin 16.4%		₩9.4bn
Q2 2025₩56.2bn+11.8%₩10.4bn
margin 18.5%		₩7.4bn
Q1 2025₩55.6bn+14.8%₩7.0bn
margin 12.6%		₩6.8bn
Q4 2024 derived₩55.1bn+31.4%₩7.5bn
margin 13.6%		₩8.4bn
Q3 2024₩50.7bn+13.3%₩9.8bn
margin 19.4%		₩7.4bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

InBody top stories 2 weeks, by number of outlets

  1. 1
    인바디·코르트, 키메스 부산 참가…체성분·혈압 관리 솔루션 공개
    4 outlets · 4 articlesFirst report Oct 23 08:46 더바이오
  2. 2
    인바디, 창립 30주년 사사 발간…체성분분석 시장 개척사 집대성
    4 outlets · 4 articlesFirst report Oct 30 08:49 뉴스1
  3. 3
    인바디 '표준이 된 30년, 세계로 향하는 100년'…창립 30주년 사사(社史) 발간
    2 outlets · 2 articlesFirst report Oct 30 09:00 인포스탁데일리
  4. 4
    너무 마른 신지…과거 근육량 부족으로 인바디 측정 불가 판정
    2 outlets · 2 articlesFirst report Oct 22 00:00 뉴시스경제
  5. 5
    '42kg 인바디 측정불가' 신지, 아파 보인다 건강이상설에 직접 해명.."감기로 고생" [Oh!쎈 이슈]
    2 outlets · 2 articlesFirst report Oct 22 08:46 조선비즈
  6. 6
    [빅데이터로본다] 건강관리장비 상장기업 2026년 10월 브랜드평판... 1위 클래시스, 2위 엘앤씨바이오, 3위 인바디
    2 outlets · 2 articlesFirst report Oct 27 07:35 일간투데이ClassysL&C Bio

Latest InBody news Korean headlines